Alvotech
NASDAQ:ALVO · NASDAQ Global Market
-$0.04 today
Vol 1.08M · Avg 0.65M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-57.06%
Period High
$9.81
Period Low
$3.00
Latest
$3.92
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Select Medical Holdings Corporation
NYSE:SEM
$2.05B
Progyny, Inc.
NASDAQ:PGNY
$2.04B
UFP Technologies, Inc.
NASDAQ:UFPT
$1.84B
Harrow Health, Inc.
NASDAQ:HROW
$1.56B
Biohaven Ltd.
NYSE:BHVN
$1.41B
Phibro Animal Health Corporation
NASDAQ:PAHC
$1.26B
Collegium Pharmaceutical, Inc.
NASDAQ:COLL
$1.08B
Evotec SE
NASDAQ:EVO
$921.71M
Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
$842.62M
Tilray Brands, Inc.
NASDAQ:TLRY
$563.33M
What is the latest ALVO filing?
The latest filing shown is 6-K dated Jun 17, 2026.
How many recent filings does ALVO have?
Intrinsic Alpha currently shows 20 recent filings for ALVO.
Explore More
Continue the stock analysis
Jump to another research area for this company.